Loading...
Population pharmacokinetic analysis of axitinib in healthy volunteers
AIMS: Axitinib is a potent and selective second generation inhibitor of vascular endothelial growth factor receptors 1, 2 and 3 approved for second line treatment of advanced renal cell carcinoma. The objectives of this analysis were to assess plasma pharmacokinetics and identify covariates that may...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Blackwell Publishing Ltd
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3952722/ https://ncbi.nlm.nih.gov/pubmed/23834452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12206 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|